Eric Cooper
Omega Fund Management, Llc
Assets Managed
$163.149M
Holdings
10
Last Quarter
2026 - Q1
Filed Date
1mo 5d ago
Growth Rate
-43.05%(2Q avg: -7.1%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Omega Fund Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 10 positions.
Assets under management
The assets under management (AUM) of Omega Fund Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 163.149M in assets, with a quarterly growth rate of -43.05% and a 2-quarter average growth rate of -7.1%. The portfolio is managed by Eric Cooper, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
BCAX Bicara Therapeutics Inc
| 29.17% | $47.58M 2.392M shares@ $19.9 avg price | Increased 8.51% |
NUVB Nuvation Bio Inc
| 21.25% | $34.668M 8.081M shares@ $4.3 avg price | |
BBOT Bridgebio Oncology Therapeut
| 18.05% | $29.442M 3.29M shares@ $8.96 avg price | |
KMTS Kestra Medical Technologies
| 12.49% | $20.371M 1.022M shares@ $19.94 avg price | Decreased -25.58% |
BBNX Beta Bionics Inc
| 8.09% | $13.188M 1.316M shares@ $10.03 avg price | |
ENGN Engene Holdings Inc
| 3.66% | $5.968M 876,357 shares@ $6.81 avg price | |
ALMS Alumis Inc
| 3.26% | $5.315M 241,255 shares@ $22.04 avg price | Decreased -63.06% |
SANA Sana Biotechnology Inc
| 1.49% | $2.43M 843,750 shares@ $2.88 avg price | |
IMA Imagenebio Inc
| 1.4% | $2.277M 455,361 shares@ $5.0 avg price | |
REPL Replimune Group Inc
| 1.18% | $1.91M 248,672 shares@ $7.69 avg price |
1-10 of 10